5th February 2020
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs provides shareholders with the following operational update: Download News5th February 2020
Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs provides shareholders with the following operational update: Download News